FDA.reportPublic FDA data

Acuitas

Primary DI
01812125010036
Brand
Acuitas
Company
Opgen, Inc.
Model
KT03U01-2
Catalog number
KT03U01-2
Device description
A reagent kit for use with Acuitas AMR Gene Panel assay; consisting of two (2) vials of PCR Master Mix and eight (8) vials of dried Assay Control which comprise enough reagents required to perform eight (8) Acuitas AMR Gene Panel assays.
Published
2021-10-06
Public version status
Update
Distribution status
Not in Commercial Distribution
MRI safety
Labeling does not contain MRI Safety Information
Rx
true
Single use
true

Contact Domains#

Product Codes#

Code, Name table
CodeName
PMYSystem, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony

Product Code Classifications#

Code, Device, Specialty table
CodeDeviceSpecialtyClass
PMYSystem, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, ColonyMicrobiology2

Identifiers And Packaging#

Identifier, Type, Agency table
IdentifierTypeAgencyPackage quantityStatus
01812125010036PrimaryGS10

Alternate GTIN / UPC / EAN Codes

Source identifier, GTIN-14 normalized, EAN-13 table
Source identifierGTIN-14 normalizedEAN-13
01812125010036018121250100361812125010036

GMDN Terms#

Term, Definition table
TermDefinition
Nucleic acid amplification mastermix kit IVDA collection of reagents and other associated materials intended to be used in combination with sequence-specific primers, probes and/or controls to facilitate the amplification of a target nucleic acid sequence [i.e., deoxyribonucleic acid (DNA) or ribonucleic acid (RNA)} in a clinical specimen, using a nucleic acid amplification technique (e.g., polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP)].

Sterilization Methods#

Method table
Method

Contacts#

Phone, Email table
PhoneEmail
301-869-9683technicalsupport@opgen.com

Regulatory Flags#

DUNS number
119234263
Device count
1
Kit
true
Lot or batch
true
Expiration date on label
true

Other Devices From This Company#

Primary DI, Brand, Model table
Primary DIBrandModelCatalogPublished
20812125010062AcuitasAC042AC0422023-04-28
01812125010067AcuitasAC042AC0422021-10-25
10812125010058AcuitasCP3402CP34022023-04-28
20812125010031AcuitasKT03U01-2KT03U01-22023-04-28
00812125010051AcuitasCP3402CP34022021-10-25
20812125010000AcuitasKT03U01-1KT03U01-12023-04-28
10812125010010AcuitasCP3230CP32302023-04-28
10812125010027AcuitasCP3445CP34452023-04-28
10812125010041AcuitasCP3233CP32332023-04-28
20812125010079AcuitasAC043AC0432023-04-28
00812125010013AcuitasCP3230CP32302021-10-25
00812125010020AcuitasCP3445CP34452021-10-25
00812125010044AcuitasCP3233CP32332021-10-25
20812125010086AcuitasCP3511CP35112023-04-28
01812125010074AcuitasAC043AC0432021-10-25
01812125010081AcuitasCP3511CP35112021-10-25
01812125010005AcuitasKT03U01-1KT03U01-12021-10-06

Other Devices Sharing Product Codes#

Primary DI, Brand, Company table
Primary DIBrandCompanyProduct codePublished
10812125010010AcuitasOpgen, Inc.PMY2023-04-28
10812125010027AcuitasOpgen, Inc.PMY2023-04-28
10812125010041AcuitasOpgen, Inc.PMY2023-04-28
10812125010058AcuitasOpgen, Inc.PMY2023-04-28
20812125010000AcuitasOpgen, Inc.PMY2023-04-28
20812125010031AcuitasOpgen, Inc.PMY2023-04-28
20812125010062AcuitasOpgen, Inc.PMY2023-04-28
20812125010079AcuitasOpgen, Inc.PMY2023-04-28
20812125010086AcuitasOpgen, Inc.PMY2023-04-28
04260364751024AcuitasCuretis GmbHPMY2023-04-17
04260364751031AcuitasCuretis GmbHPMY2023-03-15
00812125010013AcuitasOpgen, Inc.PMY2021-10-25
00812125010020AcuitasOpgen, Inc.PMY2021-10-25
00812125010044AcuitasOpgen, Inc.PMY2021-10-25
00812125010051AcuitasOpgen, Inc.PMY2021-10-25
01812125010067AcuitasOpgen, Inc.PMY2021-10-25
01812125010074AcuitasOpgen, Inc.PMY2021-10-25
01812125010081AcuitasOpgen, Inc.PMY2021-10-25
01812125010005AcuitasOpgen, Inc.PMY2021-10-06
00840733102370Revogene Carba CMERIDIAN BIOSCIENCE, INC.PMY2020-07-15
00628055344162Revogene® Carba CMeridian Bioscience Canada IncPMY2019-10-21
00628055344070GenePOC™ CarbaGenePoc IncPMY2019-05-24
07332940001032Xpert Carba-RCEPHEIDPMY2018-01-29